Back to announcements list
March 2022 Quarterly Tender
RNS Number : 5293H
CVC Credit Partners European Opps.
06 April 2022
 

6 April 2022

 

CVC Credit Partners European Opportunities Limited

(a closed-ended investment company incorporated in Jersey with registration number 112635)

Registered Office: IFC 1, The Esplanade, St Helier, Jersey, JE1 4BP

March 2022 Quarterly Tender

 

CVC Credit Partners European Opportunities Limited ("the Company") wishes to announce that the Board has opted not to limit the acceptance of the number of shares tendered for purchase in respect of the Company's March 2022 tender.

 

The number of shares by class validly tendered by shareholders in the March 2022 tender and the percentage of class shares in issue represented by these tenders as at the March 2022 Tender Record Date, are included below:

 

Share class

Shares tendered

Shares tendered as a percentage of adjusted class shares in issue as at the March 2022 Tender Record Date




Euro Shares

852,436

0.75%




Sterling Shares

3,490,001

2.62%

 

 

Subsequent Tenders

 

Pursuant to the announcement of the Company's annual financial report today, it is noted that the Company's 2022 Annual General Meeting ("AGM") will be held on or around 6 May 2022.  The next tender circular will be published alongside the 2022 AGM Notice.

 

This announcement should be read in conjunction with the Company's most-recent circular and the announcement on Monday 6 April 2020 in relation to the proposed changes to the Contractual Quarterly Tender facility.

 

Terms defined in the Company's prospectus dated 29 March 2019 have the same meaning in this announcement unless otherwise defined.

 

CVC Credit Partners European Opportunities Limited: +44 (0)1534 625522
Richard Boléat

 

BNP Paribas Securities Services S.C.A., Jersey Branch           +44 (0)1534 813873 / 709178

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGGDKVFGZZM